{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:30Z","timestamp":1747181190510,"version":"3.40.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,26]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Previous studies have shown that acetaminophen has the potential to induce hepatotoxicity in patients, rendering it a prominent drug implicated in the development of acute hepatic failure. However, there is currently no available literature reporting the impact of ibuprofen-sustained release capsules on liver failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 65-year-old man was presented with a 4-day history of tea-colored urine with oil avoidance, jaundiced skin, and anorexia, and impaired liver function. One ibuprofen-sustained release capsule was taken on the day before the onset of the disease due to \u201cheadache.\u201d<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>A diagnosis of this patient was made of liver failure due to taking ibuprofen-sustained release capsules.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Initially, the patient discontinued the use of hepatotoxic drugs in order to prevent further exposure. Subsequently, the patient underwent a standard therapeutic regimen, which encompassed the administration of hepatoprotective agents, nutritional support drugs, correction of acid-base imbalances, and electrolyte abnormalities, as well as other relevant treatments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After 9 days of hepatoprotective and nutritional supplement therapy, the patient saw notable improvement in symptoms, reporting an absence of discomfort, subsided skin jaundice, clear urine, and liver function tests returning to a near normal range. The patient was granted permission to be discharged from the hospital while being prescribed drugs. After 2 weeks of follow-up, the patient reported an absence of discomfort and exhibited normal results in the liver function test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Liver failure caused by ibuprofen-sustained release capsules has not been reported. It is worth noting that conventional treatments such as suspending offending agents, and administration of hepatoprotective agents and nutritional support drugs have proven to be successful.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lesson:<\/jats:title>\n            <jats:p>There is currently no known peer-reviewed literature indicating that the administration of ibuprofen-sustained release capsules leads to liver failure. When patients taking ibuprofen-sustained release capsules encounter symptoms such as anorexia, skin jaundice, lack of appetite, and nausea, it is recommended that they undertake a cardiac and liver function tests. In the event that ibuprofen-sustained release capsules induce liver injury, it is imperative to administer timely and immediate medical intervention.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036997","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T03:02:28Z","timestamp":1706756548000},"page":"e36997","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A unusual presentation of liver failure caused by Ibuprofen-sustained release capsules: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The People\u2019s Hospital of Lincang City, Lincang, Yunnan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3728-2350","authenticated-orcid":false,"given":"Ming-wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China"},{"name":"Department of Emergency Medicine, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1665-2681(19)30888-9","article-title":"Drug induced liver injury: accuracy of diagnosis in published reports.","volume":"13","author":"Teschke","year":"2014","journal-title":"Ann Hepatol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury.","volume":"116","author":"Chalasani","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.12324","article-title":"Review article: prescribing medications in patients with cirrhosis\u2014a practical guide.","volume":"37","author":"Lewis","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejim.2021.10.035","article-title":"Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management.","volume":"97","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Eur J Intern Med"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"114147","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective.","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archinte.1994.00420030117012","article-title":"Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors.","volume":"154","author":"Garc\u00eda Rodr\u00edguez","year":"1994","journal-title":"Arch Intern Med"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s00204-018-2237-5","article-title":"Autophagy and acetaminophen-induced hepatotoxicity.","volume":"92","author":"Shan","year":"2018","journal-title":"Arch Toxicol"},{"issue":"Suppl 6","key":"R8-20250503","doi-asserted-by":"crossref","first-page":"s104","DOI":"10.7861\/clinmedicine.16-6-s104","article-title":"Drug-induced liver injury.","volume":"16","author":"Katarey","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in Mainland China.","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.3390\/molecules28073160","article-title":"Endoplasmic reticulum stress and mitochondrial stress in drug-induced liver injury.","volume":"28","author":"Pu","year":"2023","journal-title":"Molecules"},{"issue":"2 Suppl","key":"R12-20250503","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.taap.2005.02.029","article-title":"Investigation of toxic metabolites during drug development.","volume":"207","author":"Park","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2011.02501.x","article-title":"Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity.","volume":"32","author":"Schke","year":"2012","journal-title":"Liver Int"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"e37822","DOI":"10.5812\/aapm.37822","article-title":"The Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the treatment of patients with hepatic disease: a review article.","volume":"6","author":"Soleimanpour","year":"2016","journal-title":"Anesth Pain Med"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1310\/hpj5108-623","article-title":"Ipilimumab-induced polyneuropathy; ibuprofen-induced allergic-type liver injury; trimethoprim-sulfamethoxazole-induced immune thrombocytopenia in children; Mesna-induced fixed drug eruption; digoxin-induced ocular toxicity.","volume":"51","author":"Mancano","year":"2016","journal-title":"Hosp Pharm"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/BF03261998","article-title":"Balancing the risks and benefits of the use of over-the-counter pain medications in children.","volume":"35","author":"B\u00e1rzaga Arencibia","year":"2012","journal-title":"Drug Saf"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"108159","DOI":"10.1016\/j.intimp.2021.108159","article-title":"Soliquiritigenin alleviates LPS\/D-GalN-induced acute liver failure by activating the PGC-1\u03b1\/ Nrf2 pathway to reduce oxidative stress and inflammatory response.","volume":"100","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:08:58Z","timestamp":1746317338000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036997","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,1,26]]}}}